Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

Adial Pharmaceuticals (ADIL) Other Non Operating Income (2023 - 2024)

Adial Pharmaceuticals' Other Non Operating Income history spans 2 years, with the latest figure at -$75000.0 for Q4 2024.

  • For Q4 2024, Other Non Operating Income fell 220.84% year-over-year to -$75000.0; the TTM value through Dec 2024 reached -$75043.0, changed N/A, while the annual FY2025 figure was $164854.0, 319.68% up from the prior year.
  • Other Non Operating Income for Q4 2024 was -$75000.0 at Adial Pharmaceuticals, down from -$1.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $62063.0 in Q4 2023 and bottomed at -$75000.0 in Q4 2024.